High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells

Stem Cells

Volumn 30, Issue 4, 2012, Pages 612-622

  Ben David, Uri ^a   Benvenisty, Nissim ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Chromosomal aberrations; Embryonic stem cells; Genomic instability; Induced pluripotent stem cells; Pluripotent stem cells

Indexed keywords

SURVIVIN;

ANIMAL CELL; ARTICLE; CELL NUCLEUS TRANSPLANTATION; CELL STRAIN; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 16Q; CHROMOSOME 17Q; CHROMOSOME 6; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENETIC STABILITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; TRISOMY; TRISOMY 11; TRISOMY 8; UPREGULATION;

ANIMALS; CHROMOSOME ABERRATIONS; CONSERVED SEQUENCE; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION; GENOME; HUMANS; MACACA MULATTA; MICE; PLURIPOTENT STEM CELLS; SPECIES SPECIFICITY; SYNTENY;

MACACA MULATTA;

EID: 84859503582     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1057     Document Type: Article

References (49)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
2. Baker DE, Harrison NJ, Maltby E et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol 2007;25:207-215. (Pubitemid 46227120)
3. Sugawara A, Goto K, Sotomaru Y et al. Current status of chromosomal abnormalities in mouse embryonic stem cell lines used in Japan. Comp Med 2006;56:31-34.
4. Amps K, Andrews PW, Anyfantis G et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 2011;29: 1132-1144.
5. Rebuzzini P, Neri T, Mazzini G et al. Karyotype analysis of the euploid cell population of a mouse embryonic stem cell line revealed a high incidence of chromosome abnormalities that varied during culture. Cytogenet Genome Res 2008;121:18-24. (Pubitemid 351820626)
6. Liu X, Wu H, Loring J et al. Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev Dyn 1997;209:85-91. (Pubitemid 27188341)
7. Mayshar Y, Ben-David U, Lavon N et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010;7:521-531.
8. Laurent LC, Ulitsky I, Slavin I et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011;8:106-118.
9. Hussein SM, Batada NN, Vuoristo S et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011;471: 58-62.
10. Gore A, Fung HL, Young J et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011;471:63-67.
11. Ben-David U, Mayshar Y, Benvenisty N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell 2011;9:97-102.
12. Pasi CE, Dereli-Oz A, Negrini S et al. Genomic instability in induced stem cells. Cell Death Differ 2011;18:745-753.
13. Sommer CA, Sommer AG, Longmire TA et al. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 2010;28: 64-74.
14. Yeo JC, Ng HH. Transcriptomic analysis of pluripotent stem cells: Insights into health and disease. Genome Med 2011;3:68.
15. Yang S, Lin G, Tan YQ et al. Differences between karyotypically normal and abnormal human embryonic stem cells. Cell Prolif 2010;43: 195-206.
16. Moon SH, Kim JS, Park SJ et al. Effect of chromosome instability on the maintenance and differentiation of human embryonic stem cells in vitro and in vivo. Stem Cell Res 2011;6:50-59.
17. Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 2011;11: 268-277.
18. Bignell GR, Greenman CD, Davies H et al. Signatures of mutation and selection in the cancer genome. Nature 2010;463:893-898.
19. Polo JM, Liu S, Figueroa ME et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010;28:848-855.
20. Liu L, Luo GZ, Yang W et al. Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells. J Biol Chem 2010;285:19483-19490.
21. Stadtfeld M, Apostolou E, Akutsu H et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010;465:175-181.
22. Jiang J, Ding G, Lin J et al. Different developmental potential of pluripotent stem cells generated by different reprogramming strategies. J Mol Cell Biol 2011;3:197-199.
23. Leeb M, Wutz A. Derivation of haploid embryonic stem cells from mouse embryos. Nature 2011;479:131-134.
24. Zody MC, Garber M, Adams DJ et al. DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. Nature 2006;440:1045-1049.
25. Blum B, Bar-Nur O, Golan-Lev T et al. The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol 2009;27:281-287.
26. Blum B, Benvenisty N. The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle 2009;8:3822-3830.
27. Handa Y, Hikawa Y, Tochio N et al. Solution structure of the catalytic domain of the mitochondrial protein ICT1 that is essential for cell vitality. J Mol Biol 2010;404:260-273.
28. van Belzen N, Diesveld MP, van der Made AC et al. Identification of mRNAs that show modulated expression during colon carcinoma cell differentiation. Eur J Biochem 1995;234:843-848. (Pubitemid 26023437)
29. Assou S, Le Carrour T, Tondeur S et al. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 2007;25:961-973. (Pubitemid 46572593)
30. Wu C, Orozco C, Boyer J et al. BioGPS: An extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 2009;10:R130.
31. Jung M, Peterson H, Chavez L et al. A data integration approach to mapping OCT4 gene regulatory networks operative in embryonic stem cells and embryonal carcinoma cells. PLoS One 2010;5: e10709.
32. Chia NY, Chan YS, Feng B et al. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 2010;468:316-320.
33. Lefort N, Feyeux M, Bas C et al. Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat Biotechnol 2008;26: 1364-1366.
34. Spits C, Mateizel I, Geens M et al. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol 2008;26: 1361-1363.
35. Hanna J, Cheng AW, Saha K et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci USA 2010;107:9222-9227.
36. Buecker C, Geijsen N. Different flavors of pluripotency, molecular mechanisms, and practical implications. Cell Stem Cell 2010;7: 559-564.
37. Gibbs RA, Rogers J, Katze MG et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science 2007;316: 222-234.
38. Taapken SM, Nisler BS, Newton MA et al. Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat Biotechnol 2011;29:313-314.
39. Singh AM, Dalton S. The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 2009;5:141-149.
40. Holubcova Z, Matula P, Sedlackova M et al. Human embryonic stem cells suffer from centrosomal amplification. Stem Cells 2011;29: 46-56.
41. Cervantes RB, Stringer JR, Shao C et al. Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc Natl Acad Sci USA 2002;99:3586-3590. (Pubitemid 34256391)
42. Mantel C, Guo Y, Lee MR et al. Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: A source of karyotpic instability. Blood 2007;109:4518-4527. (Pubitemid 46743423)
43. Schwartz M, Zlotorynski E, Kerem B. The molecular basis of common and rare fragile sites. Cancer Lett 2006;232:13-26. (Pubitemid 43054977)
44. Hellman A, Zlotorynski E, Scherer SW et al. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 2002;1:89-97. (Pubitemid 41039179)
45. Bester AC, Roniger M, Oren YS et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 2011; 145:435-446.
46. Helmrich A, Stout-Weider K, Hermann K et al. Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genes. Genome Res 2006;16:1222-1230. (Pubitemid 44506955)
47. Matsuyama A, Shiraishi T, Trapasso F et al. Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: Evolutionarily conserved but highly recombinogenic. Proc Natl Acad Sci USA 2003;100: 14988-14993. (Pubitemid 37518004)
48. Morelli C, Karayianni E, Magnanini C et al. Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors. Oncogene 2002;21:7266-7276. (Pubitemid 35305615)
49. Gandhi M, Dillon LW, Pramanik S et al. DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells. Oncogene 2010;29:2272-2280.